申请人:AbbVie Inc.
公开号:US20200255451A1
公开(公告)日:2020-08-13
The present disclosure provides for compounds of Formula (I)
wherein A
2
, A
3
, A
4
, A
6
, A
7
, A
8
, A
15
, R
A
, R
5
, R
9
, R
10A
, R
10B
, R
11
, R
12
, R
13
, R
14
, R
16
, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).